No. 61 Policy & regulation

Amy Abernethy

Cofounder / Co-CEO, Highlander Health / Pedestal Health • United States

An oncologist and clinical researcher who served as the Principal Deputy Commissioner of the FDA.

Share Link copied

The Signal

She spearheads national efforts in real world data generation and clinical trial modernization, integrating regulatory standards with evidence based digital health technologies and patient registries.

Who Amy Abernethy is

An oncologist and clinical researcher who served as the Principal Deputy Commissioner of the FDA.

Loading the full dossier

At a glance

Role: Cofounder / Co-CEO
Organisation: Highlander Health / Pedestal Health
Platforms: LinkedIn, X
Based in: United States, North America

Influence Score 85.7editorial estimate, see how it is built

Reach (25% weight)81

Audience size across LinkedIn, X, YouTube, podcasts and newsletters.

Engagement (20% weight)79

How much the audience actually reacts, comments, shares and subscribes.

Credibility (25% weight)96

Clinical, research, operating or investing track record behind the commentary.

Consistency (15% weight)80

Publishing cadence and how reliably they show up with original work.

Industry impact (15% weight)92

Whether decision makers, policy and capital actually move on what they say.

Scores are subjective editorial estimates compiled by our research desk from public profiles and published work. They are opinion, not measurement, and they are not a judgement of any person's character or ability.

Also in Policy & regulation

Share Link copied

Did we miss something?

Change, add or remove details on this profile. Our desk reviews every request.

This profile is compiled by our research desk from public sources and is published as editorial commentary. Want a correction, an update, or your profile removed? and see our corrections and removals policy.